The sensitivity of biologics and biosimilars regarding storage and packaging requirements as well as their complexity during administration lead to the demand to meet the highest quality standards, including strict controls at all stages in the manufacturing process. Carina Van Easter at Datwyler explains why, in the field of sensitive biologics and biosimilars, the protection of the active ingredient is of key importance, and companies are constantly seeking new packaging solutions in order to provide the utmost environment for packing and producing the drugs.